Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Hatem S Shehata"'
Autor:
Nirmeen Kishk, Hassan Hosny, Reda Badry, Ibrahim Elmenshawi, Mohamed M. Hamdy, Ehab Shaker, Hatem S. Shehata, Rehab Magdy, Gihan M. Ramzy, Mahmoud Hemeda, Ahmed Gaber, Mohamed Abdelhamed, Ahmed Abohagar, Imane A. Yassine, Mohammed Abbas, Hala A. Shaheen, Mahmoud Abdel Moety, Hussein M. H. Metwally, Mohammad Ali Saeed, Ahmed Essmat, Ashraf Abdou, Rasha Hassan Soliman, Mohammed I. Oraby, Abd El‐Naser Morad, Shaimaa Mohammed Kasem, Magdy Aidaros, Yasser El Heneedy, Ahmed ElNemr, Ahmed Elkady, Ramy Amin, Walid A. Abdel Ghany, Ahmed A. Morsy, Hussein Hamdi, Reham Shamloul
Publikováno v:
Epilepsia Open, Vol 9, Iss 4, Pp 1233-1251 (2024)
Abstract Objective In epilepsy, early diagnosis, accurate determination of epilepsy type, proper selection of antiseizure medication, and monitoring are all essential. However, despite recent therapeutic advances and conceptual reconsiderations in th
Externí odkaz:
https://doaj.org/article/e8b3cf17531f4cbf8176fe3c1e21c124
Autor:
Marwa Farghaly, Dawn W. Langdon, Nevin M. Shalaby, Hatem S. Shehata, Noha T. Abokrysha, Amr Hassan, Mohamed I. Hegazy, Alaa Elmazny, Sandra Ahmed, Shaimaa Shaheen, Alshaimaa S. Othman, Osama Yacoub, Nirmeen A. Kishk
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 57, Iss 1, Pp 1-8 (2021)
Abstract Background Given the diversity of multiple sclerosis (MS) symptoms including cognitive impairment in certain domains, the need to develop a rapid and at the same time thorough tool for cognitive assessment is mandatory and represents an unme
Externí odkaz:
https://doaj.org/article/95c06dea2cee45e5be901ea99eecf614
Autor:
Nirmeen A. Kishk, Walaa Abdelfattah, Nevin M. Shalaby, Hatem S. Shehata, Amr Hassan, Mohamed I. Hegazy, Noha T. Abokrysha, Doaa Abdellatif, Shereen M. Shawky, Sarah S. Abdo, Noha Taha, Amr M. Fouad, Alaa Elmazny, Amany H. Ragab
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background In Egypt, the characterization of Neuromyelitis Optica Spectrum Disorder (NMOSD) is lacking. Objectives To determine the demographics, clinical features, aquaporin4 antibodies (AQP4-IgG) status, and neuroimaging of Egyptian NMOSD
Externí odkaz:
https://doaj.org/article/abe3c11d298940348166d85508a20804
Autor:
Talaat A. Hassan, Shaima Fattouh Elkholy, Hatem S. Shehata, Nevin M. Shalaby, Alaa N. Elmazny, Mohamed N. Sadek, Bahaa Eldin Mahmoud, Mona M. Elsherbiny
Publikováno v:
The Egyptian Journal of Radiology and Nuclear Medicine, Vol 52, Iss 1, Pp 1-7 (2021)
Abstract Background Multiple sclerosis (MS) is a major cause of neurological disability in adults. Depression is one of the most common psychiatric comorbidities in MS patients with negative impact on patients’ quality of life. The aim of the study
Externí odkaz:
https://doaj.org/article/b8262b26d2074698969414ad2e04daae
Autor:
Doaa A. Mekkawy, Sherif Hamdy, Maged Abdel-Naseer, Hatem S. Shehata, Ahmed Al Halfawy, Nevin M. Shalaby, Ghaydaa A. Shehata, Anwar M. Ali, Alaa Elmazny, Sandra M. Ahmed, Jumana H. Ismail, Aml Ibraheim, Hoda M. Abdel-Hamid, Rehab Magdy, Younan Kabara Ayoub, Ahmed E. Taha, Nahla Merghany, Nourhan M. Soliman, Haidy Elshebawy, Samar E. S. Abdelal, Lobna El-Ghoneimy, Aussan Al-Athwari, Nirmeen A. Kishk, Mona A. F. Nada, Marwa Farghaly, Amr Hassan, Mohamed I. Hegazy, Ahmed Abdelalim, Husam S. Mourad, Amira Hassouna, Alshimaa S. Othman, Tissa Wijeratne
Publikováno v:
Brain Sciences, Vol 12, Iss 1, p 74 (2022)
Background: The COVID-19 pandemic has reached over 276 million people globally with 5.3 million deaths as of 22nd December 2021. COVID-19-associated acute and long-term neurological manifestations are well recognized. The exact profile and the timing
Externí odkaz:
https://doaj.org/article/1388f776e73c4e69b1cb581a9cf6f44e
Publikováno v:
Revue Neurologique. 177:647-654
Background Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS). Aberrant expression of transcription factor forkhead box P3 (FoxP3) has been suggested to underlie different immunological disorders as FOXP3 expr
Autor:
Alshaimaa S. Othman, Alaa Elmazny, Shaimaa Shaheen, Nirmeen A. Kishk, Sandra M. Ahmed, Dawn Langdon, Osama Yacoub, Mohamed I Hegazy, Nevin M. Shalaby, Marwa Farghaly, Hatem S Shehata, Noha T. Abokrysha, Amr Hassan
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 57, Iss 1, Pp 1-8 (2021)
Background Given the diversity of multiple sclerosis (MS) symptoms including cognitive impairment in certain domains, the need to develop a rapid and at the same time thorough tool for cognitive assessment is mandatory and represents an unmet need in
Autor:
Nirmeen Kishk, Hassan Hosny, Reda Badry, Ibrahim Elmenshawi, Mohamed M. Hamdy, Ehab Shaker, Hatem S. Shehata, Rehab Magdy, Gihan M. Ramzy, Mahmoud Hemeda, Ahmed Gaber, Mohamed Abdelhamed, Ahmed Abohagar, Imane A Yassine, Mohammed Abbas, Hala A. Shaheen, Mahmoud Abdel Moety, Hussein M H Metwally, Mohammad Ali Saeed, Ahmed Essmat, Ashraf Abdou, Rasha Hassan Soliman, Mohammed I. Oraby, Abd El-Naser Morad, Shaimaa Mohammed Kasem, Magdy Aidaros, Yasser El Heneedy, Ahmed ElNemr, Ahmed Elkady, Ramy Amin, Walid A. Abdel Ghany, Ahmed A. Morsy, Reham Shamloul
In epilepsy, early diagnosis, accurate determination of epilepsy type, proper selection of anti-seizure treatment, and monitoring; all are essential. However, despite recent therapeutic advances and conceptual reconsiderations in the classification a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::704d2f0235914108fc7fa8377b83db4b
https://doi.org/10.21203/rs.3.rs-1519715/v1
https://doi.org/10.21203/rs.3.rs-1519715/v1
Autor:
Mohamed Nasreldin Sadek, Mona M. Elsherbiny, Shaima Fattouh Elkholy, Nevin M. Shalaby, Talaat A. Hassan, Hatem S Shehata, Bahaa Eldin Mahmoud, Alaa Elmazny
Publikováno v:
The Egyptian Journal of Radiology and Nuclear Medicine, Vol 52, Iss 1, Pp 1-7 (2021)
BackgroundMultiple sclerosis (MS) is a major cause of neurological disability in adults. Depression is one of the most common psychiatric comorbidities in MS patients with negative impact on patients’ quality of life. The aim of the study is to eva
Autor:
Hatem S Shehata, Mona A.F. Nada, Mohamed I Hegazy, Sherif Hamdy, Alaa Elmazny, Nevin M. Shalaby, Sandra M. Ahmed, Rehab Magdy, Nirmeen A. Kishk, Amr Hassan, Maged Abdel-Naseer, Husam S Mourad, Ahmed Abdelalim, Ehab Shaker, Alshimaa S. Othman, Doaa Mekkawy
Publikováno v:
Therapeutics and Clinical Risk Management. 16:759-767
The ongoing coronavirus (COVID-19) pandemic is a global health emergency of international concern and has affected management plans of many autoimmune disorders. Immunosuppressive and immunomodulatory therapies are pivotal in the management of neurom